Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.45 Million shares of MRNA, which is worth approximately $47.4 Million. The most recent transaction as insider was on Sep 01, 2023, when has been sold 652 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M
0.47% 3M change
3.36% 12M change
Total Value Held $47.4 Million

Stephen Hoge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2023
BUY
Exercise of conversion of derivative security
-
652 Added 0.04%
1,589,507 Common Stock
Aug 29 2023
SELL
Open market or private sale
$130,536 $115.01 p/Share
1,135 Reduced 0.07%
1,588,855 Common Stock
Aug 28 2023
BUY
Exercise of conversion of derivative security
-
2,411 Added 0.15%
1,589,990 Common Stock
Aug 17 2023
SELL
Open market or private sale
$1,500,000 $100.0 p/Share
15,000 Reduced 0.94%
1,587,579 Common Stock
Aug 10 2023
SELL
Open market or private sale
$25,324 $102.53 p/Share
247 Reduced 0.02%
1,602,579 Common Stock
Aug 09 2023
BUY
Exercise of conversion of derivative security
-
523 Added 0.03%
1,602,826 Common Stock
Jul 17 2023
SELL
Open market or private sale
$1,809,000 $120.6 p/Share
15,000 Reduced 0.93%
1,602,303 Common Stock
Jun 15 2023
SELL
Open market or private sale
$1,888,950 $125.93 p/Share
15,000 Reduced 0.92%
1,617,303 Common Stock
Jun 02 2023
SELL
Open market or private sale
$40,268 $130.32 p/Share
309 Reduced 0.02%
1,632,303 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
-
651 Added 0.04%
1,632,612 Common Stock
May 30 2023
SELL
Open market or private sale
$147,565 $124.95 p/Share
1,181 Reduced 0.07%
1,631,961 Common Stock
May 26 2023
BUY
Exercise of conversion of derivative security
-
2,410 Added 0.15%
1,633,142 Common Stock
May 10 2023
SELL
Open market or private sale
$33,342 $133.37 p/Share
250 Reduced 0.02%
1,630,732 Common Stock
May 09 2023
BUY
Exercise of conversion of derivative security
-
522 Added 0.03%
1,630,982 Common Stock
Mar 02 2023
SELL
Open market or private sale
$160,578 $136.43 p/Share
1,177 Reduced 0.07%
1,630,460 Common Stock
Mar 01 2023
SELL
Open market or private sale
$147,968 $138.03 p/Share
1,072 Reduced 0.07%
1,629,031 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
-
2,606 Added 0.16%
1,631,637 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
2,410 Added 0.15%
1,630,103 Common Stock
Feb 10 2023
SELL
Open market or private sale
$40,155 $163.9 p/Share
245 Reduced 0.02%
1,627,693 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
522 Added 0.03%
1,627,938 Common Stock
Nov 29 2022
SELL
Open market or private sale
$188,573 $173.8 p/Share
1,085 Reduced 0.07%
1,627,416 Common Stock
Nov 28 2022
BUY
Exercise of conversion of derivative security
-
2,410 Added 0.15%
1,628,501 Common Stock
Nov 10 2022
SELL
Open market or private sale
$38,251 $165.59 p/Share
231 Reduced 0.01%
1,626,091 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
-
522 Added 0.03%
1,626,322 Common Stock
Sep 13 2022
SELL
Open market or private sale
$269,020 $136.42 p/Share
1,972 Reduced 0.12%
1,625,800 Common Stock

Also insider at

AXLA
Axcella Health Inc. Healthcare
Stephen Hoge

Stephen Hoge

President
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA